| Literature DB >> 35906275 |
Eliana-Isabel Rodríguez-Grande1,2, Adriana Buitrago-López3,4,5, Martha-Rocio Torres-Narváez6, Yannely Serrano-Villar7, Francisca Verdugo-Paiva8,9, Camila Ávila9.
Abstract
The effects and the prescription parameters of therapeutic exercise are not clear. For this reason, is needed to determine the effect of therapeutic exercises on the motor function of children with Down Syndrome (DS) aged 0 to 3 years. The present study is systematic review and meta-analysis of effectiveness outcomes in this population: gait, balance, motor development, fine motor skills, and executive functions. The databases of PubMed, PEDro, EMBASE, SCIELO, Lilacs, Cochrane library were searched from January to December 2019. We recruited Randomized Controlled Trials (RCTs) which met the inclusion criteria in our study. Six studies and 151 participants were included. Two types of therapeutic exercises, aerobic and neuromuscular, were identified. Both types of exercise were effective in improving outcomes. There were no differences between the modes of application of the exercise. No differences were identified between the treadmill and the physiotherapy plan for the reduction of the time to reach independent walking, Mean Difference (MD) 46.79, 95% Confidence Interval (IC) (- 32.60, 126.19), nor for the increase in walking speed MD 0.10 IC (- 0.02, 0.21) m/s. This study suggests that aerobic exercise therapy has a potentially effective role to promote the gait and motor development of children with DS aged 0 to 3 years when it is applied using a treadmill with a frequency of 5 days, a duration of 6-8 min, and an intensity of between 0.2 and 0.5 m/s. Studies with less heterogeneity and larger sample sizes are required.Entities:
Mesh:
Year: 2022 PMID: 35906275 PMCID: PMC9338268 DOI: 10.1038/s41598-022-16332-x
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.996
Primary studies and reports.
| References of the studies included in this review: | Reports linked to the studies included in this review: |
|---|---|
| 1. Looper, Ulrich (2010) Effect of treadmill training and supramalleolar orthosis use on motor skill development in infants with Down syndrome: a randomized clinical trial[ | Looper, Ulrich (2011) Does orthotic use affect upper extremity support during upright play in infants with down syndrome?[ |
| 2. Wu, Looper, Ulrich, Ulrich, Angulo-Barroso (2007). Exploring effects of different treadmill interventions on walking onset and gait patterns in infants with Down syndrome[ | Wu, Looper, Ulrich, Angulo-Barroso (2010). Effects of various treadmill interventions on the development of joint kinematics in infants with Down syndrome[ Angulo-Barroso, Wu, Ulrich. (2008). Long-term effect of different treadmill interventions on gait development in new walkers with Down syndrome[ Ulrich, Lloyd, Tiernan, Looper, Angulo-Barroso (2008). Effects of intensity of treadmill training on developmental outcomes and stepping in infants with Down syndrome: a randomized trial[ |
| 3. Angulo-Barroso, Burghardt, Lloyd, Ulrich (2008). Physical activity in infants with Down syndrome receiving a treadmill intervention[ | Lloyd, Burghardt, Ulrich, Angulo-Barroso (2010). Physical activity and walking onset in infants with Down syndrome[ |
| 4. Harris (1981). Effects of neurodevelopmental therapy on motor performance of infants with Down’s syndrome[ | |
| 5. Ulrich, Ulrich, Angulo-Kinzler, Yun (2001). Treadmill training of infants with Down syndrome: evidence-based developmental outcomes[ | |
| 6. Lowe, McMillan, Yates (2015). Body Weight Support Treadmill Training for Children With Developmental Delay Who Are Ambulatory[ |
Figure 1PRISMA flowchart of selection of articles included in the systematic review. Adapted from: Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021;372:n71. https://doi.org/10.1136/bmj.n71. For more information, visit:
www.prisma-statement.org.
Figure 2Risk of bias summary: review authors’ judgments on each risk of bias item for each included study. Revman 5. https://training.cochrane.org/online-learning/core-software-cochrane-reviews/revman.
Figure 3Risk of bias graph: review authors' judgments on each risk of bias item presented as percentages across all included studies. Revman 5. https://training.cochrane.org/online-learning/core-software-cochrane-reviews/revman.
Characteristics of the studies included regarding therapeutic exercise in children with DS aged 0 to 3 years.
| Reference | Participants | Interventions | Outcomes, measurement tools | Application parameters | Results |
|---|---|---|---|---|---|
| Looper, J 2010[ | DI: NR N: 17 H:NR M:NR Age 21.4 ± 4 months | EG: Treadmill and orthosis (eight hours a week), regular physiotherapy CG: treadmill, regular physiotherapy | * Independent gait: days to the event (gait: 3 independent steps) * Motor function: GMFM | EG: 206 ± 109 days from the beginning of the intervention until the event CG: days to the event 268 ± 88 Higher scores in the group without orthosis at one-month follow-up EG: GMFM pos 195.65 ± 8.12 CG: GMFM pos 183.78 ± 7.22 | |
| Wu, J 2010[ | DI: NR N:30 H:18 M:12 Age 10.4 ± 2.14 months | EG: Treadmill at generally low intensity CG: Treadmill at individualized high intensity | Step length, stride length, speed Bayley Scales for Infant Development | Differences favoring group 1, both in months to the event and in gait parameters p < 0.05 EG: 19.2 months from the beginning of the intervention until event CG: 21.4 months to event | |
| Angulo-Barroso, R. 2008[ | DI: NR N:30 H:18 M:12 Age 10.4 ± 2.2 months | EG: Treadmill at generally low intensity CG: Treadmill at individualized high intensity | * Independent gait: days to the event (gait: 3 independent steps) *Parameters | EG significant differences in time to event and in the development of the kinematic parameters of gait compared to CG p < 0.05 | |
| Harris, S. R.1981[ | DI: NR N:20 H:9 M:11 Age 10.91 ± 7.64 months | EG: neurodevelopmental therapy CG: activities of daily living | Bayley and Peabody Scales (fine and gross motor skills) | There were no significant differences between the groups, however, the experimental group showed significant differences between the initial and final measurement | |
| Ulrich, D. A 2001[ | DI: NR N:30 H:NR M:NR Age 9.2 ± 0.5 months | EG: Treadmill and comprehensive physiotherapy GC: comprehensive physiotherapy | EG: 73.8 days from the beginning of the intervention until the event CG: days to event 101 days | ||
| Lowe L 2015[ | DI: NR N: 24 H:17 M:7 Age 26 to 51 months | EG: PT sessions and 3 additional body weight supported treadmill training sessions CG: PT sessions consisting of therapeutic activities to promote functional stability and mobility | There were no significant differences in any of the dimensions assessed |
GMFM: Gross Motor Function Measure; EG: experimental group; CG: control group.
Figure 4Aerobic exercise (treadmill) versus control (activities of daily living) outcome: independent gait, time(days)-to-event.
Assessing the certainty of the evidence presented for each outcome.
| No. of studies | Study design | Risk of bias | Inconsistency | Indirect evidence | Imprecision | Other considerations | Therapeutic exercise | Placebo | Absolute (95% CI) | Certainty |
|---|---|---|---|---|---|---|---|---|---|---|
| Independent gait: three steps without assistance. Treadmill-type aerobic Therapeutic exercise vs. control (assessed: days-to-event) | ||||||||||
| 3 | Randomized trials | Very serious a | Not serious b | Not serious | Serious b | No effect was observed | 41 | 41 | MD (32.6 lower than 126.19 higher.) | ⨁⨁◯◯ LOW |
| Motor development (mental dimension) intervention: neuromuscular exercise vs control (regular interventions) (assessed: Gross motor function measure) | ||||||||||
| 1 | Randomized trials | Not serious | – | Serious c | Serious b | No effect was observed | 10 | 10 | MD | ⨁⨁◯◯ LOW |
| Motor development (motor dimension): intervention: neuromuscular exercise vs control (regular interventions) (assessed: Gross motor function measure) | ||||||||||
| 1 | Randomized trials | Not serious | – | Serious c | Serious b | No effect was observed | 10 | 10 | MD | ⨁⨁◯◯ LOW |
| Gait speed follow-up 4 and 6 weeks intervention: aerobic exercise-weight-supported treadmill training vs regular intervention | ||||||||||
| 1 | Randomized trials | Serious d | – | Not serious | Serious b | No effect was observed | 12 | 12 | MD (-0.02 lower than 0.21 higher.) | ⨁⨁◯◯ LOW |
| Motor development follow-up 4 and 6 weeks intervention: aerobic exercise-weight-supported treadmill training vs regular intervention (assessed with: GMFM) | ||||||||||
| 1 | Randomized trials | Serious d | – | Not serious | Not serious b | No effect was observed | 12 | 12 | MD (0.28 higher than 3.86 higher.) | ⨁⨁⨁◯ MODERATE |
MD: mean difference. aThe methods of randomization and the blinding of the evaluators are not clear. There is selective and incomplete reporting of results in one of the studies and doubt in the others; bConfidence intervals are wide; they cross the line of no effect. cPopulation with intellectual disability including Down Syndrome. dThe methods of randomization are not clear.